A number of studies have attempted to characterize HIV-1-associated mucosal cytokine expression. [1] [2] [3] [4] [5] [6] Unfortunately, the studies have used varied methodologies (in situ hybridization, 2, 3 reverse transcription polymerase chain reaction [RT-PCR], 5 enzyme-linked immunosorbent assay [ELISA]-based protein assessment, 1 and functional assays of isolated mucosal mononuclear cells 4 ) to measure cytokines and virus in intestinal tissue. This methodologic heterogeneity makes direct comparisons difficult, and the problem is further exacerbated by the rapidly changing nature of HIV-1 therapeutics. Many of the earlier studies were conducted before the widespread availability of combination antiretroviral therapy (ART) and plasma-based viral load assays such that the clinical characterization of the study populations is limited. In addition, the recent reductions in HIV-1-associated enteric infection 7 suggest that combination therapy is able to induce significant immune reconstitution, which would not be seen in these earlier studies.
Cytokine networks undoubtedly play a critical role in AIDS pathogenesis; thus, this study was undertaken using quantitative PCR techniques to measure cytokine and HIV-1 gene expression in the same intestinal tissue samples from a group of well-characterized patients. Measuring viral replication in tissue rather than plasma allows a more accurate assessment of the relation between gut-associated lymphoid tissue (GALT), viral infection, and the role of cytokine networks in controlling infection in an environment or tissue milieu in which local cytokine concentration far exceeds that measured in plasma. The rationale for choosing specific cytokines/chemokines in this study was as follows. RANTES is a chemoattractant for activated lymphocytes, drawing them into sites of inflammation, such as the gut. Tumor necrosis factor (TNF)-␣, interleukin (IL)-2, and IL-6 are proinflammatory cytokines that stimulate HIV-1 replication. In addition, these cytokines/chemokines are known to be elevated in noninfectious inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease. The mucosal diseases associated with the two major variants of IBD have been classified as T helper (Th) 1 (Crohn's disease) and Th2 (ulcerative colitis) 8 ; thus, IL-1␤, interferon (IFN)-␥, and IL-12 were chosen as prototypic Th1 cytokines and IL-10 as a Th2 cytokine to determine whether a similar Th1/Th2 stratification may occur with varying levels of HIV-1 MVL.
In addition to the cross-sectional data generated in this study, we have included longitudinal data from 2 patients in whom we were able to measure sequential tissue viral load and cytokine profiles after the initiation and withdrawal of ART. These data are included to allow a preliminary assessment of the dynamic relation between MVL load and cytokine expression.
METHODS

Subjects
HIV-1-positive subjects and seronegative healthy controls were recruited from clinic patients, clinical trial subjects, and local volunteers. Most HIV-positive (18 of 25) subjects had stable disease and were asymptomatic. The remaining 7 subjects were being evaluated for gastrointestinal symptoms, but opportunistic infections were not identified in any cases. All subjects signed informed consent forms, and the David Geffen School of Medicine at the University of California at Los Angeles (UCLA) Institutional Review Board approved the protocol. Subject characteristics, including gender, age, Centers for Disease Control and Prevention (CDC) class, CD4 + T-cell count, plasma viral load (PVL), MVL, antiretroviral medications, years of HIV-1 infection, and clinical status, were collected at the time of endoscopy and are shown in Table 1 .
On the basis of MVL quantification, the HIV-1-infected subjects were divided into 3 study groups: (1) undetectable MVL (<50 copies/µg of tissue total RNA), (2) low MVL (>50 to <5000 copies/µg of tissue total RNA), and (3) high MVL (>5000 copies/µg of tissue total RNA).
Collection of Intestinal Tissue Samples
Rectosigmoid biopsies were collected endoscopically using a flexible sigmoidoscope as previously described.
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Measurement of Mucosal Viral Load
The MVL was measured using real-time quantitative PCR with a modification of our previously published technique 9 in which P-32 end-labeled primers were replaced with fluorogenic probes as described below.
Total RNA was extracted from 3 intestinal biopsies using a TRIzol isolation technique (Invitrogen, Carlsbad, CA). RT of 5 µg of total RNA was accomplished using a First Strand ProSTAR RT-PCR kit (Stratagene, Cedar Creek, TX) in conjunction with random primers. Briefly, 5 µg of total RNA was adjusted to a final volume of 38 µL in diethyl pyrocarbonate (DEPC) water before the addition of 3 µL of random primers. After a 5-minute incubation at 65°C, each reaction was cooled to room temperature to permit annealing of primers. Nine microliters of a reaction mix containing 5 µL of ×10 buffer, 1 µL of RNAase block, 2 µL of 100-mM deoxynucleotide triphosphate (dNTP), and 1 µL of Moloney Murine Leukemia virusreverse transcriptase (MMLV-RT) enzyme (50 U/µL) was added, and samples were incubated for 60 minutes at 37°C. The reaction was terminated by heating to 90°C for 5 minutes.
Cytokine primers optimized for real-time PCR were designed using the cDNA sequences of the gene of interest from the GenBank database in conjunction with Primer Express software (Applied Biosystems, Foster City, CA). PCR products were designed to be approximately 150 base pairs (bp) in size, and each cytokine product was verified to be of the anticipated size by agarose gel electrophoresis. Melting point analysis confirmed the amplification of single products. HIV-1 RNA was then quantified by real-time PCR using the Geneamp 5700 sequence detection system (Applied Biosystems).
The primer sequences were as follows 5Ј-GCT AAC TAG GGA ACC CAC TGC TT-3Ј, 5Ј-CTG CTA GAG ATT TTC CAC ACT GAC TAA-3Ј, and the probe (6-FAM) TTA CCA GAG TCA CAC AAC AGA CGG GCA (TAMRA-FAM). One cycle of denaturation (95°C for 10 minutes) was performed, followed by 40 cycles of amplification (95°C for 15 seconds and 60°C for 1 minute). RNA standards (10-3000 copies) constructed by the in vitro transcription of cloned HIV-1 RNA were included with each series of reactions. Standards were diluted in 100 ng of HIV-1-seronegative tissue RNA prepared by our extraction protocol. Copies were expressed per microgram of tissue total RNA; sensitivity was 10 copies/µg of tissue total RNA as previously demonstrated. 9 All assays were performed in triplicate, and a mean calculated from the 3 measurements was obtained.
Measurement of Plasma Viremia
The PVL was measured at the UCLA Center for AIDS Research Virology Core Laboratory using the Roche Amplicor HIV-1 monitor ultrasensitive viral load assay (version 1.5), with a lower limit of detection of <50 copies HIV-1 RNA per milliliter of plasma.
Measurement of Cytokine Expression in Intestinal Tissue
RNA extraction and reverse transcription were accomplished using the techniques described previously. Relative quantitation of cytokine gene expression was performed with the Applied Biosystems Geneamp 5700 sequence detection system (Applied Biosystems) using the standard curve method. Briefly, a standard curve was generated for each cytokine of interest using a stock of serially diluted cDNA generated from peripheral blood mononuclear cells stimulated overnight with 10 µg/mL of phytohemagglutinin (PHA; Sigma, St. Louis, MO) and appropriately designed oligonucleotide primers. Primers were optimized by performing a primer matrix experiment in which 3 primer concentrations (50, 300, and 900 nm) are tested in combination. The optimum concentration was determined for each primer pair and was defined as the minimum primer concentration giving the maximum increase in cycle threshold with the minimum nonspe-cific amplification. Nonspecific amplification was monitored by performing a melting curve analysis.
The following primers and probes were used: RANTES (5Ј-CTA CAC CAG TGG CAA CTG CT-3Ј, 5Ј-TCC CGA ACC CAT TTC TTC T-3Ј), TNF␣ (5Ј-CTC CAC CCA TGT GCT CCT CAC-3Ј, 5Ј-ATG GCA GAG AGG AGG TTG ACC-3Ј), IL-6 (5Ј-GCT GCA GGA CAT GAC AAC TC-3Ј, 5Ј-CAA CAA TCT GAG GTG CCC AT-3Ј), IL-1␤ (5Ј-GGC AGA AGT ACC TGA GCT CG-3Ј, 5Ј-CTG TTT AGG GCC ATC AGC TT-3Ј), IL-10 (5Ј-GCT GAG AAC CAA GAC CCA GAC-3Ј, 5Ј-GGA AGA AAT CGA TGA CAG CG-3Ј), IL-2 (5Ј-CAA CTG GAG CAT TTA CTG CTG-3Ј, 5Ј-GCC TTC TTG GGC ATG TAA AA-3Ј), IFN␥ (5Ј-ATG TCC AAC GCA AAG CAA TA-3Ј, 5Ј-CGA CCT TGA AAC AGC ATC TG-3Ј), and IL-12 (5Ј-ACC CAA CAA CTT GCA GCT GAA-3Ј, 5Ј-TGG ACC TGA ACG CAG AAT GTC-3Ј). Each 50-µL PCR reaction mixture contained 1 to 3 µL of sample cDNA, and the final concentration of each component was as follows: 5 µL ×10 SYBR Green buffer, 7 µl of 25 mM MgCl 2 ), 4 µL of dNTP blend (2.5 mm each of dATP, dGTP, and dCTP and 5.0 mm of dUTP), 0.25 µL of Amplitaq Gold (5 U/µL), 0.5 µL of Amperase UNG, and 50 to 300 nm of each primer. The direct detection of PCR products was monitored by measuring the increase in fluorescence caused by the binding of SYBR Green to double-stranded DNA. Standardization across samples was achieved by expressing cytokine copy number per 10 6 ␤-actin copies per sample. All assays were performed in triplicate, and a mean calculated from the 3 measurements was obtained.
Statistical Analysis
The small unequal sample sizes in each group, heterogeneity between groups, and nonnormality of the data suggested that standard analysis of variance (ANOVA) techniques are inappropriate. Thus, for each cytokine, nonparametric ANOVA was conducted using the Steel-Dwass procedure with the Baumgartner test as described in the reports by Neuhauser and Bretz 10 and Baumgartner et al. 11 Exact P values, adjusted for examining all pairwise differences, were computed from the permutation distribution of the test statistic under the null hypothesis of no group differences. This methodology is more powerful and less conservative than the Wilcoxon tests with Bonferroni-Dunn adjustments. Attention is drawn to pairwise comparisons with an adjusted P value below 0.1. Associations in levels of cytokines were summarized through Spearman nonparametric rank correlations (Table 2) . Rank-order correlations between pairs of cytokines across all groups higher than 0.4 were statistically significant at the P = 0.05 level (Fig. 1) .
Pairwise rank-order correlations are also provided for individual groups. Because sample sizes were quite small, however, formal statistical inference is not provided.
RESULTS
Patient Characteristics
Demographic characteristics for the 32 subjects in this study are presented in Table 1 . Two groups were included in the study: a control group consisting of 7 healthy volunteers and an HIV-1-infected group consisting of 25 subjects. There were statistically significant differences between the control and HIV-infected study groups in terms of age, although there were no significant differences between the individual HIV groups. After quantification of MVL, the HIV-1-infected group was divided into 3 subgroups: undetectable MVL (n = 7), low MVL (n = 7), and high MVL (n = 11).
All the subjects in the undetectable MVL group were receiving ART and had undetectable PVLs. In the low MVL group, 6 of the 7 subjects were on ART, and the mean PVL was 4.10 log 10 copies/mL of plasma (range: 2.92-4.62). In the high MVL group, 7 of the 11 subjects were on ART, and the mean PVL was 4.66 log 10 copies/mL of plasma (range: 3.73-5.47). The mean PVL in the high MVL group was higher than that in the low MVL group, but the difference was not significant. The mean CD4 count was highest in the undetectable MVL group but did not differ significantly from that in the low and high MVL groups.
Quantitative Tissue Viral Load
By definition, all the patients in the undetectable MVL group had undetectable MVL (MVL <50 copies/µg of tissue total RNA). In the low MVL group, the mean MVL was 2.72 log 10 copies/µg of tissue total RNA (range: 2.22-3.11). In the high MVL group, the mean MVL was 4.20 log 10 copies/µg of tissue total RNA (range: 3.72-4.99). 
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The entire undetectable MVL group had undetectable PVL (PVL <50 copies/mL of plasma). In addition, the mean PVL in the high MVL group (4.66 log 10 copies/mL of plasma) was higher than the mean PVL in the low MVL group (4.10 log 10 copies/mL of plasma). In this study, however, we were unable to demonstrate a significant correlation between PVL and MVL when data were pooled from all 3 HIV-positive groups.
Cytokine Profiles Stratified by Mucosal Viral Load
Cytokine data for the 4 study groups are summarized in Table 2 . Differing patterns of cytokine expression were seen in the 3 HIV-1-infected groups when compared with the control group (Fig. 2) .
Controls and Undetectable Mucosal Viral Load Group
The undetectable MVL group was characterized by reduced cytokine expression compared with the control group.
Significant reductions were seen in IL-2, IFN␥, IL-10, RANTES, and TNF␣ expression. IL-1␤ and IL-12 were both reduced, but the differences did not reach statistical significance. The only exception to this pattern was IL-6, which was significantly increased in all the HIV-1 groups, irrespective of MVL.
Controls and Low Mucosal Viral Load Group
Subjects in the low MVL group did not differ from the control group, with the exception of IL-6, which was significantly increased.
Controls and High Mucosal Viral Load Group
The high MVL group was characterized by generalized increases in cytokine expression. Significant increases were seen in IL-2, IFN␥, IL-10, RANTES, IL-6, and IL-1␤ expression. TNF␣ and IL-12 were also increased, but the differences did not reach statistical significance. 
Comparisons Between the Mucosal Viral Load Groups
The low MVL group had significantly higher levels of RANTES, TNF␣, and IFN␥ expression compared with the undetectable group. The high MVL group had significantly higher levels of RANTES, TNF␣, IL-1␤, IL-10, IL-2, and IFN␥ expression compared with the undetectable MVL group. The high MVL group had significantly higher levels of RANTES, IL-10, and IFN␥ expression compared with the low MVL group.
Relation Between T Helper 2/T Helper 1 Profiles and Mucosal Viral Load
The IL-10/IFN␥ ratio was significantly reduced in the low and high MVL groups compared with the undetectable MVL group and nonsignificantly reduced compared with the control group, suggesting that active mucosal viral replication was associated with a predominant Th1 environment. The undetectable MVL IL-10/IFN␥ ratio was slightly increased compared with control group, suggesting a Th2 response, but the differences were not significant.
Relation Between Individual Cytokines
Data were analyzed to determine whether changes in individual cytokine expression were correlated with similar changes in other cytokines. When data were pooled from all 4 study groups, significant correlations were seen between most cytokines (see Table 3 ), with the exception of TNF␣ and IL-6, IL-1␤ and IL-6, RANTES and IL-12, TNF␣ and IL-12, IL-6 and IL-12, and IFN␥ and IL-12.
When the mucosal cytokine data were analyzed by study group, a number of differences from the pooled analysis were noted. As an example, there was a positive correlation between IFN␥ and IL-2 in the pooled data. In contrast, there was no correlation between IFN␥ and IL-2 in the high MVL group.
Cytokine Profiles After Initiation or Cessation of Antiretroviral Therapy
Cytokine Profiles After Initiation of Antiretroviral Therapy
Subject 485 was a 49-year-old man who initiated ART with a combination of lamivudine, saquinavir, ritonavir, and stavudine at a time when his PVL was 5.07 log 10 copies/mL of plasma, MVL was 3.72 log 10 copies/µg of total RNA, and CD4 count was 146 × cells/mm 3 . Over a period of 8 weeks, both PVL and MVL fell by greater than 3 logs and became undetectable (Fig. 3) . During this period, cytokine expression remained fairly stable, although by week 8, there were modest reductions in IL-2, IFN␥, IL-10, RANTES, and IL-6 expression and small increases in IL-1␤ and TNF␣ expression.
Cytokine Profiles After Cessation of Antiretroviral Therapy
Subject 493 was a 36-year-old man who discontinued ART after experiencing drug toxicity. At the time of discontinuation, his PVL was undetectable and his MVL was 1.59 log 10 copies/µg of total RNA. CD4 count data were not available. By week 4, his PVL and MVL had risen by greater than 3 logs (see Fig. 2 ). During this period, cytokine expression gradually increased, and by week 12, there were increases in IL-2, IFN␥, IL-10, RANTES, IL-6, IL-1␤, and TNF␣.
DISCUSSION
In this study, we have demonstrated that there are significant correlations between mucosal cytokine expression and Elevated levels of TNF␣ and IL-1␤ protein were found in tissue homogenates from HIV-1-infected but not control patients. In a later study, the same group demonstrated increased expression of TNF␣ mRNA colocalizing with HIV-1 RNA in rectal tissue using in situ hybridization. 2 Using a wider range of 35S-labeled riboprobes, Reka et al 3 described a variation in the expression of HIV-1 RNA and mucosal cytokine RNA during the progression of HIV-1 infection. IFN␣, IFN␥, and TGF␤ were most prevalent in early disease; IL-4, IL-5, IL-6, and IL-10 were increased in intermediate disease; and peak expression of TNF␣ and IL-1␤ mRNA was seen in patients with AIDS. In contrast, Steffen et al 4 demonstrated reduced production of TNF␣, IL-1␤, IL-6, and IFN␥ by isolated intestinal mononuclear cells from AIDS patients when stimulated with pokeweed mitogen. A comprehensive, although qualitative, RT-PCR characterization of mucosal cytokine expression in 50 HIV-1-infected subjects showed increases in small intestinal production of mRNA for IL-1␤ and IFN␥ and a reduction in large intestinal production of IL-10 mRNA. 5 Focusing on patients with HIV-associated diarrhea, Snijders et al 6 were unable to demonstrate cytokine-mediated inflammation in homogenized jejunal biopsies. The most striking difference between these studies is the divergent mRNA and protein data. It has been suggested that posttranslational control mechanisms may be responsible for this situation. 6 We have previously published evidence of increases in proinflammatory cytokines, including RANTES, using quantitative immunohistochemistry in HIV-1-infected intestinal tissue, however, suggesting that gene expression is translated into protein expression. 12 The observation that HIV-1-infected subjects with undetectable MVL have reduced cytokine expression compared with controls is intriguing and may represent a mucosal re- sponse to ART. The normal intestinal mucosa has a level of physiologic inflammation, which occurs, in part, as a response to ongoing luminal antigenic stimulation. 13 This natural inflammation is tightly regulated, and failure of control mechanisms can result in chronic IBD such as Crohn's disease or ulcerative colitis. 8 To explain the diminished cytokine expression seen in subjects with undetectable MVL, it would be necessary to postulate that ART itself had a locally suppressive effect on the immunologic effector cells of the intestinal mucosa or was associated with profound changes in luminal antigenic load. Although there are no data that directly support the former hypotheses, it is known that successful antiviral regimens can have variable effects on cytokine production 14 while eradicating enteric opportunistic infections through improved mucosal immune responses. 15, 16 A recent study looking at unstimulated peripheral blood mononuclear cell cytokine expression during chronic primate lentivirus infection produced evidence of a similar divergent cytokine response depending on the animals' level of viremia. 17 The finding of generalized cytokine activation associated with high MVL is less surprising. Cytokine dysregulation associated with HIV-1 infection is well described and probably occurs in the high MVL group secondary to active viral replication within mucosal mononuclear cells. The significant increase in proinflammatory cytokines such as RANTES, IL-6, and IFN␥ is likely to increase the local inflammatory response, allowing further cycles of infection to occur.
The use of a Th1/Th2 paradigm 18 has been widely used to describe aspects of HIV-1 pathogenesis and has also been used in gastrointestinal and other disease. 19 Although increasing MVL was associated with a rise in Th1 profile (defined by IL-10/IFN-␥ ratios), analysis of the cytokine data revealed several significant correlations that again did not conform to a Th1/Th2 paradigm.
Although we did not find a significant correlation between MVL and PVL overall, the mean PVL in the high MVL group (4.66 log 10 copies/mL of plasma) was higher than that in the low MVL group (4.1 log 10 copies/mL of plasma). The undetectable MVL group was selected to have undetectable MVL but also had undetectable PVL. This combination is unusual and reflects an intentional selection bias used to define a virologically homogeneous cohort of one extreme. In previous studies, we have shown that HIV-1 RNA can be recovered from approximately 65% of subjects with undetectable PVL, 9, 11 although copy number tends to be low. Contemporary treatment paradigms advocate the use of combination ART to suppress active viral replication and induce a state of clinical and virologic latency in which some degree of immune reconstitution occurs and disease progression is suspended. Unfortunately, problems of drug toxicity, patient adherence, and the constant ability of the HIV-1 virus to mutate and escape antiretroviral pressure mean that this period of virologic suppression is often transitory. The subjects in this study with undetectable PVL and MVL were all receiving ART and represent treatment successes with concomitant absence of cytokine activation and, indeed, a state of relative cytokine hypoactivation. In contrast, the subjects with low or high MVL, many of whom were receiving ART, represent relative treatment failures. These subjects had detectable PVL as a result of nonadherence to their antiretroviral regimen and/or the development of resistance mutations. The generalized cytokine activation seen in these subjects could be regarded as the consequence of viral activation, irrespective of its cause. Nevertheless, exploration of the exact relation between viral replication and cytokine dysregulation is limited by the cross-sectional nature of this study. In this regard, the longitudinal data from the subject stopping ART (see Fig. 2 ) provide interesting, if preliminary, data suggesting that increased viral replication is associated with and, in this case, precedes progressive cytokine activation.
In summary, we have used quantitative real-time PCR techniques to characterize the relation between MVL and local cytokine expression and have demonstrated that increased MVL occurs in a setting of increased PVL and is associated with generalized cytokine activation that does not conform to a specific Th1/Th2 pattern of cytokine dysregulation. Limited longitudinal data suggest that increased cytokine activation is a consequence of local viral replication. Successful ART resulting in undetectable PVL and MVL is associated with decreased cytokine activity, although the implications of this are unclear. The complex pattern of cytokine dysregulation associated with HIV-1 infection, together with the knowledge that cytokine networks exhibit considerable pleiotropy and redundancy, suggests that attempts to manipulate expression of individual cytokines may have limited therapeutic success. Strong antiviral immune responses to HIV infection may be beneficial to the infected subject. Proinflammatory immune responses may actually have harmful consequences, however, through activation of target cells and increased vulnerability to HIV infection. 20 The vast reservoir of GALT is likely to be a key site of such an interaction. Therapeutic intervention with immunosuppressive drugs such as cyclosporin A in primary and established HIV-1 infection has shown promise, 21, 22 and it is of interest that cyclosporin A is also routinely used to treat intestinal mucosal inflammation found in severe ulcerative colitis. 23 Targeting GALT with immunotherapeutic agents that downregulate proinflammatory responses may provide a new approach to HIV therapy.
